Reliant Medical Group Earns National Recognition for Cardiovascular Disease Management
Worcester, MA— For the second consecutive year, Reliant Medical Group has been recognized by the American Heart Association (AHA) for gold-level achievement in three clinical quality programs aimed at reducing the risk of heart disease and stroke through management of high blood pressure, type 2 diabetes, and high cholesterol.
Gold level in the 2021 Target: BP™ Recognition Program recognizes Reliant and other physician practices across the country that have 70 percent or more of their adult patient’s BP controlled. High BP or hypertension is a leading risk factor for heart attacks, strokes, and preventable death in the U.S. According to the AHA, there are 121.5 million U.S. adults living with high BP and less than half of those people have their BP under control – making the diagnosis and effective management of hypertension critical to better health.
The Type 2 Diabetes℠ Gold Award recognizes practices that have improved the quality of care through awareness, detection, and management of type 2 diabetes by educating and empowering patients with evidence-based information and tools. Data submitted by Reliant showed impressive HbA1c control in patients with diabetes and 70% or more adherence to one of the cardiovascular-focused clinical measures. According to the AHA, cardiovascular disease is the leading cause of death for people living with type 2 diabetes.
Gold-level recognition in the 2021 Check. Change. Control. CholesterolTM program recognizes healthcare systems for improving quality of care through awareness, detection, and management of high cholesterol. To receive gold-level recognition, practices must fulfill the participant criteria and have 70% or more of their adult, at-risk atherosclerotic cardiovascular disease patient population appropriately managed with statin therapy. One of the major controllable risk factors for heart disease, heart attack and stroke, high cholesterol typically has no symptoms.
“Reliant is honored to be recognized for the important work we do in helping patients manage the key risk factors that cause heart attacks, stroke and other cardiovascular problems,” commented Tarek Elsawy, President and CEO of Reliant Medical Group. “This care is essential to improving our patients’ health and helping them to avoid exacerbation of these serious conditions.”
“Heart disease and strokes continue to be a leading cause of death for Americans,” remarked James Langabeer, Ph.D., FAHA, volunteer expert for the American Heart Association and Professor and Vice Chair of Emergency Medicine with McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). “We are pleased to recognize Reliant Medical Group for their commitment to managing the risk factors for patients around critical risk factors like high blood pressure, high cholesterol and type 2 diabetes.”